lenalidomide,dexamethasone,selinexor,bortezomib
karyopharm therapeutics
['bortezomib', ' lena', 'borte', 'dexamethasone', 'selinexor', 'multiplemyeloma', 'lenalidomide']
a study presented at the congress shows #selinexor triple therapy with bortezomib and dexamethasone improves survival in patients with lenalidomide-refractory #multiplemyeloma. find out more here 
Hospital Healthcare Europe is the official publication of HOPE, and the most powerful information source for public #hospitals in the #UK and #EU